<DOC>
	<DOC>NCT00794118</DOC>
	<brief_summary>The primary purpose of this observational study is to describe and define the current daily practice of management of anti-TNF-agents in Rheumatoid Arthritis (RA) patients. Data will be collected only from subjects providing informed consent.</brief_summary>
	<brief_title>Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>1. Eighteen years of age or older 2. Diagnosis of RA in accordance with ARA 1987 classification has satisfied at least 4 of the following 7 criteria: 1. Morning stiffness in and around the joints lasting at least 1 hour; 2. Arthritis of 3 or more joint areas; 3. Arthritis of hand joints; 4. Symmetric arthritis. simultaneous involvement of the same joint areas on both sides of the body; 5. Rheumatoid nodules; 6. Serum Rheumatoid Factor (RF) 7. Radiographic changes. Criteria 1 through 4 must have been present for at least 6 weeks. 3. Patients refractory or without complete response to DMARDs according to the Italian Guidelines for the clinical practice established by Italian Society of Rheumatology 4. Patients naive to antiTNF drugs 5. Outpatients Patients involved in controlled or interventional trials in the 12 previous months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>